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Sharif S Aly1,2*, Patrick Pithua3, John D Champagne1 and Deborah M Haines4,5Abstract
Background: The objective of this randomized controlled trial was to determine the effect of feeding a commercial
lacteal-derived colostrum replacer (CR) or pooled maternal colostrum (MC) on preweaning morbidity, growth and
mortality in Holstein heifer calves. A total of 568 calves were randomly assigned to be fed either 3.8 L of pooled MC
or two doses (200 g IgG) of a CR. Calves were monitored daily for preweaning morbidity until weaning at 60 d old.
Birth and weaning weights were measured to estimate growth rates.
Results: Calves fed CR were significantly less likely to be affected with a diarrhea event (OR = 0.58; 95% CI, 0.38 to
0.88; P value = 0.011) and had a higher rate of daily weight gain (0.051 kg/day; 95% CI, 0.03 to 0.08; P value <0.001)
compared to calves fed pooled MC. Use of lacteal-derived colostrum replacer was not significantly associated with
respiratory disease (OR = 1.01; 95% CI 0.67 to 1.51; P value = 0.974 ), omphalitis (OR = 0.93; 95% CI 0.06 to 14.86;
P value = 0.956), or mortality (HR = 0.71; 95% CI 0.27 to 1.92; P value = 0.505) in the study calves.
Conclusions: The lacteal-derived CR fed at the study dose was a viable colostrum alternative in the event of poor
quality pooled MC for the prevention of preweaning diarrhea and resulted in higher growth rates in comparison to
calves fed pooled MC in the study herd.
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Bovine maternal colostrum (MC) contains immune fac-
tors that provide a critical first line of defense against a
variety of infectious pathogens to which calves become
exposed after birth [1]. There is consensus in the litera-
ture that at least 3.8 L of good-quality MC (IgG >50 g/L
and Total Plate Counts, TPC <100,000 cfu/mL) should
be administered to prevent failure of passive transfer
(FPT) of immunity, a condition characterized by serum
IgG < 10 g/L ≥ 24 h post colostrum ingestion in calves
[2-4]. Failure of passive transfer of immunity is a well-* Correspondence: saly@ucdavis.edu
1Veterinary Medicine Teaching and Research Center, School of Veterinary
Medicine, University of California, Davis, 18830 Road 112, Tulare, CA 93274,
USA
2Department of Population Health and Reproduction, School of Veterinary
Medicine, University of California, One Shields Avenue, Davis, CA 95616, USA
Full list of author information is available at the end of the article
© 2013 Aly et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orrecognized risk factor for increased preweaning calf
morbidity and mortality [5-8]. The condition has also
been associated with milk yield losses and decreased lon-
gevity in lactating adult cows [5,6].
Adequate intake of MC is critical for preventing FPT
and its negative consequences on calf health and future
production performance. Several studies have confirmed
the presence of bovine specific pathogens (e.g. Escherichia
coli, Salmonella sp., Mycoplasma sp., bovine leukemia
virus, and Mycobacterium avium subsp. paratuberculosis)
in MC suggesting that feeding raw MC is an early means
by which newborn calves can become exposed to such
pathogens [9-15]. In addition, negative correlations have
been reported between bacterial contamination levels in
colostrum and post-feeding serum IgG concentrations
[3,16]. Hence, feeding colostrum of inferior quality (IgG <
50 g/L and TPC > 100,000 cfu/mL) can exacerbate the risk. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ance [3].
Colostrum replacers derived from either spray-dried
bovine plasma or spray-dried cow colostrum are formu-
lated to provide ≥ 100 g of IgG to calves when ingested
at the replacer dose [17]. Specific heat treatment must
be utilized along with spray-dry processing of the plasma
or colostrum to effectively destroy all pathogens present
in MC [18]. Therefore, CR products have the potential
to limit calf exposure to bovine pathogens that may be
shed or contaminate MC and are indicated for calves
when quality or quantity (or both attributes) of raw MC
may be compromised.
Previous IgG absorption studies on various CR prod-
ucts yielded conflicting results [19-22]. In addition, stud-
ies that report a positive association between bovine
lacteal or serum based CR products and adequate trans-
fer of immunity in calves rarely include an assessment of
preweaning morbidity and performance [19-21]. In one
Minnesota study, 93% of calves fed a plasma-derived CR
product (125 g of IgG) after birth experienced FPT com-
pared with 28% of calves fed MC [19]. Even so,
preweaning morbidity and mortality risks did not differ
between groups in this study [22]. Several studies
reported that feeding a higher IgG mass (≥ 200 g of IgG)
delivered using CR products resulted in greater IgG ab-
sorption and lower FPT risks [19,20,23]. However, these
studies did not evaluate post-administration perform-
ance in terms of preweaning morbidity and mortality
risks, feed intake, and weight gain for calves fed larger
masses of IgG in the CR products evaluated.
We recently completed a study comparing IgG and
serum total protein (TP) in calves fed pooled MC or
lacteal-derived CR [24]. In that study, serum TP and IgG
concentrations at approximately 24 hours post-colostral
intake were significantly lower for calves fed pooled MC
(TP = 4.77 g/dL, SD = 0.55; IgG = 7.50 g/L, SD = 5.0)
compared to calves fed CR (TP = 5.50 g/dL, SD = 0.52;
IgG = 15.15 g/L, SD = 4.75). Colostrum IgG concentra-
tion and mass fed were significantly higher in the CR
(71.4 g/L; 200 g, respectively) compared with MC group
(21.08 g/L, SD = 9.77; 79.79 g, SD = 36.96, respectively).
The apparent efficiency of IgG absorption (AEA) was
similar for calves fed MC (28.79%, SD = 2.098) or CR
(26.98%, SD = 1.65). A significantly higher proportion of
calves fed MC (188/269 [70%]) suffered from FPT
(serum IgG < 10 g/L) compared with calves fed CR (32/
292[11%]) (P < 0.001). However, producers are often inter-
ested not only in passive transfer of immunity in calves,
but also in preweaning health and growth rates. The ob-
jective of this randomized trial was to determine the effect
of feeding a higher dose of a commercial lacteal-derived
CR or pooled MC on preweaning morbidity, daily weight
gain and mortality in Holstein heifer calves.Results
Descriptive data
In total, 568 newborn calves were enrolled in the study.
Of these, 273 (48%) were fed pooled MC while 295
(52%) were fed lacteal derived-CR. Calves did not signifi-
cantly differ in birth weight, precolostral serum IgG or
total protein between trial groups (P value > 0.05). In
addition, calves fed MC or CR did not differ in time to
separation from dam (2.35 hours (SD = 2.42) and 2.34
(SD = 2.42), respectively) and time to feeding colostrum
(3.99 hours (SD = 2.31) and 4.12 hours (SD = 2.25),
respectively).
Preweaning health and mortality events and the mean
birth and weaning weights are summarized in Table 1.
The proportion of calves with diarrhea, and those
treated with antibiotics were significantly higher for
calves fed pooled MC compared with calves fed lacteal-
derived CR. However, the proportions of calves with re-
spiratory disease, omphalitis or those that died in the
preweaning period were similar between groups (CR vs.
pooled MC, Table 1). The preweaning mean daily weight
gain was significantly higher (P < 0.0001, Table 1) in
calves fed lacteal-derived CR compared with calves fed
pooled MC.
Multivariable models
Heifer calves fed lacteal-derived CR were significantly less
likely to experience a preweaning event of diarrhea (OR =
0.58; 95% CI = 0.38 to 0.88) (Table 2). Similarly, calves fed
lacteal-derived CR were less likely to be treated with anti-
biotics during the preweaning period (OR =0.66; 95% CI =
0.47 to 0.93), compared with calves fed pooled MC. While
calves fed 200 g IgG in lacteal-derived CR (vs. pooled MC)
at birth experienced significantly higher preweaning mean
daily weight gain by 0.051 kg/d (95% CI = 0.026 to 0.075;
P value < 0.001), the risk of respiratory disease and
omphalitis was not dependent on the type of colostrum
fed (Table 2). In addition, the Hazard Rate Ratio (HRR) es-
timated from the Cox proportional hazard model showed
that there was no significant effect of type of colostrum
fed on the hazard for mortality (HRR = 0.71; 95% CI = 0.27
to 1.92; P = 0.505).
Based on findings from this study, we estimate that
routine feeding of 200 g of IgG (formulated as the
current lacteal-derived CR powder) instead of pooled-
MC could eliminate approximately one-fifth of the cases
of diarrhea (Population Attributable Fraction, PAF =
0.21; 95% CI = 0.03 to 0.35) and approximately one-
tenth of the number of antibiotic-treated calves (PAF =
0.12; 95% CI 0.02 to 0.22) in this population (Table 3).
Discussion
As reported elsewhere [24], a significantly higher pro-
portion of calves fed pooled-MC (70%) suffered from
Table 1 Comparison of preweaning morbidity, growth and mortality in a randomized trial of the effect of feeding a
lacteal-derived colostrum replacer (CR) or pooled maternal colostrum (MC) in calves
Treatment group P value
Lacteal-derived CR Pooled MC
Estimate n 95% Confidence
interval
Estimate n 95% Confidence
interval
Lower Upper Lower Upper
Number of calves enrolled 295 273
Preweaning health events
Diarrhea (%) 15.9 47 11.8 20.1 24.5 67 19.4 29.6 0.011
Respiratory disease (%) 21.4 63 16.7 26.0 21.2 58 16.4 26.1 0.974
Omphalitis (%) 0.3 1 0.0 1.0 0.4 1 0.0 1.1 0.956
Treatment with antibiotics (%) 33.6 99 28.2 38.9 43.2 118 37.3 49.1 0.018
No health events or treatments (%) 63.4 187 57.9 68.9 54.2 148 48.3 60.1 0.026
Preweaning mortality/100 calves, 60-day follow-up period 2.4 7 0.6 4.1 3.3 9 1.2 5.4 0.506
Mean birth weight (kg) 39.1 293 38.5 39.7 39.4 269 38.8 40.1 0.452
Weaning weight (kg) 58.9 275 57.9 59.8 57.0 248 56.0 57.9 0.006
Mean daily weight gain (kg/day) 0.405 274 0.388 0.422 0.355 247 0.337 0.372 <0.001
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lacteal-derived CR (11%). Failure of passive transfer of
immunity is a well-recognized predictor for increased
preweaning calf morbidity [5-8]. It is therefore not sur-
prising that calves fed raw pooled MC in this study were
more likely to be treated with antibiotics or experience
preweaning event of diarrhea compared with calves fed
lacteal-derived CR in the study herd.
Bovine specific pathogens (Salmonella sp., Escherichia
coli, Mycoplasma sp.) are frequently shed in colostrum
of infected fresh cows either during an epidemic or
intermittently during the peripartum period [3]. It is
possible that the higher proportion of diarrhea in
preweaned calves fed pooled MC (vs. lacteal-derived CR)Table 2 Final model estimates for preweaning morbidity and





Diarrhea Lacteal-derived CR 295 4
Pooled MC 273 6
Respiratory disease Lacteal-derived CR 295 6
Pooled MC 273 5
Omphalitis Lacteal-derived CR 295
Pooled MC 273
Treatment with antibiotics Lacteal-derived CR 295 9
Pooled MC 273 1
Healthy calves** Lacteal-derived CR 295 1
Pooled MC 273 1
* OR is the ratio of the odds of outcome in calves fed lacteal-derived CR to the odd
** Calves raised from birth to weaning without morbidity or treatment with antibiowas a consequence of direct ingestion of such pathogens
in pooled MC. However, this theory could not be further
investigated given that culture of the pooled MC sam-
ples for specific pathogens (example Salmonella sp.,
Escherichia coli, Mycoplasma sp.) was not performed in
the current study.
Our results indicate that only 21% of diarrhea cases
and 12% of antibiotic-treated calves would be eliminated
in this population if the pooled MC feeding program
was replaced by 200 g IgG/ calf delivered in a lacteal-
derived CR product. This should not be surprising given
that in replacement heifer rearing, improved preweaning
health is a function of several factors including reducing
calf exposure to risk factors (infectious agents inclusive).mortality events in a randomized trial of the effect of
o pooled maternal colostrum (MC) in calves
es β coefficient (SE) P value OR* (95% CI)
ents
7 −0.540 (0.212) 0.011 0.58 (0.38 to 0.88)
7 Reference –
3 0.007 (0.205) 0.974 1.01 (0.67 to 1.51)
8 Reference –
1 −0.078 (1.417) 0.956 0.93 (0.06 to 14.86)
1 Reference –
9 −0.410 (0.174) 0.018 0.66 (0.47 to 0.93)
18 Reference –
87 0.380 (0.171) 0.027 1.46 (1.05 to 2.05)
48 Reference –
s of outcome in calves fed pooled maternal colostrum.
tics.
Table 3 Population Attributable Fraction (PAF) for
feeding raw pooled maternal colostrum compared to a
lacteal-derived colostrum replacer at birth to Holstein
heifer calves on a California dairy on preweaning
diarrhea and treatment with antibiotics in a
randomized trial
PAF
Item Estimate (%) 95% Confidence
interval
P value
Diarrhea 21 3.3 to 35 0.021
Treated with
antibiotics
12 1.5 to 22 0.026
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lation, and general hygiene; increasing levels of specific
and non-specific immunity through providing good qual-
ity colostrum, balanced nutrition, stress minimization; and
boosting specific resistance through preventive vaccina-
tions of either the dams or newborn calves against specific
pathogens [22,25,26]. Calves in the present study were
housed in raised individual wooden hutches up to 60 d of
age and maintained on preweaning diets of milk replacer,
calf starter grain, and fresh water ad libitum. While a
number of calf management practices were in place to
reduce calf exposure to risk factors for disease in the
current herd, it is possible that some yet unidentified
factor (unrelated to pooled MC) may have contributed
to the additional risk of diarrhea (e.g. compromised
sanitation) leading to increased antimicrobial use on
this specific farm.
The overall finding that calves fed raw pooled MC (vs.
lacteal-derived CR) were more likely to be treated with
antibiotics or experience preweaning diarrhea differed
from a previous report [22]. Swan et al. reported no dif-
ference in post-feeding morbidity risk observed between
calves fed a plasma-derived CR compared with calves
fed individual maternal colostrum (i.e. non-pooled colos-
trum) [22]. In contrast, another study found significantly
lower morbidity risk for calves fed MC (46.9%) com-
pared with calves fed a lacteal-derived CR (67.3%) [27].
Although not statistically significant, Priestley et al.
reported that a greater proportion of calves fed a lacteal-
derived CR experienced diarrhea (44.9%) compared to
calves fed MC (28.6%) [27,28]. Although some studies
have found no link between FPT and the risk of treat-
ment for diarrhea in beef calves, a possible reason for
the difference in findings could be the higher proportion
of FPT in calves fed MC in the current study, and in
calves fed a lacteal-derived CR (vs. MC) in the Priestley
et al. study [27-29]. The difference in FPT is likely to be
due to better quality MC fed to calves in the aforemen-
tioned studies compared to the current study [22,27]. In
a recent survey, 41% of individual colostrum samples met
industry recommended colostrum quality benchmarks(IgG >50 g/L and TPC <100,000 cfu/mL) compared with
only 26% of pooled colostrum samples [30,31]. The mean
IgG mass in the pooled MC fed to the calves in this study
was approximately 21 g/L compared with approximately
69.7 g/L of IgG reported for non-pooled colostrum in the
recent survey of colostrum quality [24,30].
While there were no differences in the proportion of
preweaning respiratory disease, omphalitis or death in
calves fed lacteal-derived CR compared to those fed
pooled MC, mean daily weight gain was significantly
higher in the former. This reflected perhaps a general
benefit accruing from the improved preweaning health
outcomes associated with feeding lacteal-derived CR ra-
ther than a direct role in enhancing daily weight gain in
the study calves [2]. Such a link between reduced mor-
bidity and increased weight gain was also reported in a
Florida study, although unlike in the current study, the
Florida study reported reduced morbidity in calves fed
MC compared to those fed a lacteal-derived CR [27,28].
In the current study, type of colostrum fed (CR versus
MC) had no effect on mortality risk between birth and
weaning in the study calves. These results are consistent
with results from an earlier study in which feeding a
plasma-derived CR (vs MC) had no effect on preweaning
mortality [22]; however they differed from the Florida
study which found a significantly lower proportion of
mortality in calves fed MC compared to calves fed a
lacteal-derived CR [27]. These contradictions may reflect
the fact that in concert with passive transfer of immun-
ity, calf survival in the preweaning period is a function
of several herd factors including housing and nutrition.
Although a major strength of this study included its ran-
domized assignment of treatment, the results presented
here must be interpreted cautiously. It is possible that the
ability to correctly assign a disease diagnosis (i.e. diarrhea,
respiratory disease, omphalitis) varied among the study
personnel involved in the care of the calves during the
follow-up period. This potential bias, if present, was likely
to be non-differential because the study personnel were
blinded to treatment group assignment (lacteal-derived
CR vs. pooled MC). Moreover, a veterinarian (SA) cross-
validated each recorded diagnosis and treatment with the
herd veterinarian’s drug protocols. The extent to which
this study’s results can be extrapolated to a wider popula-
tion of dairy herds is limited by the use of a single herd to
evaluate the current study objectives. While approximately
57% of large dairy operations in the US routinely feed
pooled MC [31], the current herd was not representative
of this wider population with respect to FPT risk profiles
and quality of pooled MC fed. Recent findings [32] suggest
that approximately 23% of calves in US operations that fed
pooled MC experienced FPT compared with 70% of calves
fed the pooled MC in this study. In addition, the mean
IgG mass in the pooled MC fed to the calves in this study
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tion in nationally representative samples of pooled MC
[30]. The lower quality of the pooled MC fed to calves in
this study compared to comparable US herds likely biased
the morbidity outcomes in a direction suggestive of a bet-
ter efficacy for the lacteal-derived-CR for improving
preweaning health in calves. Hence, it is possible that the
benefits of feeding lacteal-derived CR (vs. pooled MC) on
preweaning health may not be similar in dairy herds man-
aged under a different husbandry system.
The findings reported here indicate that producers
should adopt colostrum management strategies that im-
prove colostrum quality. To achieve this, producers can
begin by pooling only colostrum with acceptable im-
munoglobulin concentration (>50 g/liter IgG). This can
be achieved by testing individual cow colostrum sam-
ples prior to pooling and by properly identifying dams
so that first milking colostrum is pooled separate from
colostrum harvested from subsequent milkings. Alter-
natively, pooling colostrum can be replaced by feeding
a colostrum replacement product with a known im-
munoglobulin concentration. Other recommendations
identified from previous research should also be followed
such as observing proper sanitation and hygiene during
harvesting, processing, and storage of colostrum, feeding
colostrum replacement products or heat-treated colos-
trum [2,3,33].
Conclusions
In this study, calves fed CR had a significantly higher
rate of daily weight gain and were less likely to be af-
fected with diarrhea compared to calves fed MC. Type
of colostrum fed was not predictive of the preweaning
risks for pneumonia and mortality in this particular
herd. Although a major strength of this study included
its randomized design, the extent to which the current
findings can be extrapolated to a wider population of
dairy herds may be limited by the use of a single herd.
Methods
This study was approved by the Institutional Animal
Use and Care Committee at the University of California,
Davis and the University of Missouri –Columbia (Proto-
col # 6439).
Herd selection criteria
This study was conducted in a 3,600 milking Holstein
dairy in California that routinely fed 3.8 L of raw pooled
MC to newborn calves. The study herd was selected
based on its large size, maintenance of electronic records
through participation in the California Dairy Herd Infor-
mation Association routine milk testing and willingness
of the owner to comply with the study requirements.
Monthly bulk tank milk cultures conducted over the12 months prior to the study were negative for Myco-
plasma species by culture on Hayflick medium and en-
richment broth.
Feeding protocols and experimental design
A total of 568 newborn calves were enrolled in the study
between September and December, 2010 while the fol-
low up period ended in March 2011. Pregnant dams
were moved to a group calving pen approximately 3 d
prior to the expected calving date and monitored until
calving. Heifer calves born between 6 AM and midnight
were separated from their dams immediately after birth.
Cows calving otherwise were monitored by the dairy’s
night shift staff and newborn calves were removed im-
mediately after birth to the holding pen until fed the
assigned colostrum type by study personnel the follow-
ing morning. Once in the holding pen, each calf had its
navel dipped in an iodine-based antibacterial solution,
its ear tagged and its dam ID recorded on farm paper
records.
Calves were randomized to one of two treatment
groups and fed either 3.8 L of raw pooled MC (control
group, n = 273) or two doses of a lacteal-derived CR
(Land O Lakes Colostrum Replacement, Lake O Lakes
Animal Milk Products) (treatment group, n = 295). The
CR was reconstituted based on the manufacturer’s in-
structions as follows. Each package (100 g IgG/dose) of
the lacteal-derived CR powder was dissolved in 1 L of
warm water (approx. 49°C) yielding a mixture of 1.4 L
containing 71.4 g/L of IgG. Maternal colostrum was
harvested after morning milking sessions within 1 to
12 h of calving, pooled and refrigerated at 4°C until feed-
ing within 6–12 h of collection. Both the lacteal-derived
CR and pooled MC were administered as a single oral
dose (CR ~ 2.8 L and MC ~3.8 L) within 6 h of birth. All
calves were fed using a bottle nipple. However, when a
calf failed to ingest some or all of the colostrum quan-
tity, an esophageal tube feeder was used to deliver the
complete dose in lieu of the bottle.
Following feeding, each calf was housed in an individ-
ual raised wooden hutch until weaning at approximately
60 d of age. During the preweaning period, calves were
fed daily diets consisting of 2 L of pasteurized hospital
pen milk, clean water and a starter grain mix.
Enrollment and preweaning health monitoring
Before feeding the assigned colostrum type, calves were
bled for serum IgG and TP concentration estimation.
Calves were also weighed (kg) at birth and weaning
which occurred at approximately 60 days of age. Other
data recorded included dam identification, colostrum
type fed (lacteal-derived CR or pooled MC), birth date,
time from birth to separation from dam (h), time from
birth to colostrum feeding (h), quantity of colostrum fed
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used to administer the colostrum.
Calf morbidity from birth to weaning were monitored
and recorded daily by trained study personnel including
study authors (SA and JC) while blinded to the type of
colostrum fed (lacteal-derived CR or pooled MC) at en-
rollment. For uniformity in morbidity recordings the fol-
lowing working definitions were applied based on a
modification of the University of Wisconsin Calf Health
Scoring Chart (http://www.vetmed.wisc.edu/dms/fapm/
fapmtools/8calf/calf_health_scoring_chart.pdf ): (I) diar-
rhea was indicated in calves that voided abnormal feces
with watery consistency and foul smell (score 2 or 3) with
or without dehydration or elevated body temperature
(≥ 40°C), (II) respiratory disease was reported for calves
that exhibited increased respiratory rate, nasal dis-
charges, or cough (score 1, 2 or 3 except no attempt
was made to induce a cough) with or without an ele-
vated body temperature (≥ 40°C), (III) omphalitis (navel
infections) was associated with presence of overt umbil-
ical inflammatory signs, including heat, swelling, puru-
lent discharges, or evidence of pain on palpation of the
umbilical area. Furthermore, a calf ’s joints were physic-
ally examined for heat if a joint or umbilicus appeared
enlarged. Treatments including antibiotics administered
by the dairy’s staff to the study calves were recorded on
a daily basis. No specific treatment protocols were de-
veloped for this study. Instead, dairy staff relied on pro-
tocols implemented by the herd veterinarian. All
morbidity events and treatments recorded were vali-
dated by a veterinarian (SA).
Statistical analysis
An estimate for daily weight gain (DWG) for each calf
was calculated using the following formula: DWG =
(WWT-BWT)/ T; where DWG=Daily weight gain (kg),
WWT =weaning weight (kg), BWT = birth weight (kg),
T = age of the calf at weaning (d). Mean ± standard error
of the mean (SEM) for birth weights, weaning weights,
and daily weight gains were calculated. The proportion
of calves with an event of diarrhea, respiratory disease,
omphalitis, and treated with antibiotics during the
preweaning period were calculated for each group (lac-
teal-derived CR vs. pooled MC). Similarly, the propor-
tion of healthy calves defined as the proportion of calves
that did not experience a morbidity event and were not
treated with antibiotics from birth to weaning was com-
pared between the study groups. The distribution of the
preceding variables between groups (lacteal-derived CR
vs. pooled MC) was tested using t-tests for continuous
variables (birth weight, weaning weights and daily weight
gain) and Pearson χ2-test for categorical variables (diar-
rhea, respiratory disease, omphalitis, and preweaning
treatments with antibiotics, healthy calves, and death).The association between type of colostrum fed (lac-
teal-derived CR vs. pooled MC) and diarrhea, respiratory
disease, omphalitis, treatment with antibiotics, or produ-
cing a healthy calf from birth to weaning were investi-
gated by fitting 5 separate logistic regression models to
the data for each outcome. Birth weight and the method
by which colostrum was fed (tube vs. bottle feeding)
were presented to each model as additional independent
variables in a manual forward stepwise selection proced-
ure. Variables that significantly improved model fit based
on the Akaike Information Criterion (AIC) values and
likelihood ratio test P < 0.05 were retained or else ex-
cluded from the final models. Population attribution
fractions for lacteal-derived CR as a predictor of diar-
rhea, and treatment with antibiotics in the study calves
were estimated separately. Population attributable frac-
tions were estimated using the approach of Greenland
and Drescher [34].
Next, to quantify the effect of feeding a lacteal-derived
CR (vs. pooled MC) on preweaning time (d) to death, a
Cox proportional hazards regression model was fitted to
the preweaning mortality data to compare the hazard
rate (HR) for mortality in calves fed CR to the HR in
calves fed MC using the HRR [35]. Graphical evaluation
of the Cox proportional hazard assumption for the treat-
ment group (pooled MC vs. lacteal-derived CR) variable
revealed no evidence of violation of the proportional
hazards assumption [36].
Finally, a simple least-squares regression model was
fitted to the data to evaluate the effect of treatment (lac-
teal-derived CR (vs. pooled MC) on daily weight gain.
Data was analyzed using standard software (Stata® Corp.,
College Station, TX, USA). A 5% level of significance
was indicative of statistical significance.Competing interest
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